Background Gastric carcinoids are slow growing neuroendocrine tumours arising from enterochromaffinlike (ECL) cells in the corpus of stomach. Although most of these tumours arise in the setting of gastric atrophy and hypergastrinemia, it is not understood what genetic background predisposes development of these ECL derived tumours. Moreover, diffuse microcarcinoids in the mucosa can lead to a field effect and limit successful endoscopic removal. Objective To define the genetic background that creates a permissive environment for gastric carcinoids using transgenic mouse lines. Design The multiple endocrine neoplasia 1 gene locus (Men1) was deleted using Cre recombinase expressed from the Villin promoter (Villin-Cre) and was placed on a somatostatin null genetic background. These transgenic mice received omeprazole-laced chow for 6 months. The direct effect of gastrin and the gastrin receptor antagonist YM022 on expression and phosphorylation of the cyclin inhibitor p27
INTRODUCTION
Neuroendocrine tumours (NETs) develop primarily in the GI tract, pituitary and parathyroid glands, pancreas and lungs. [1] [2] [3] GI-NETs in the stomach are specifically labelled gastric carcinoids (GCs). GCs are relatively rare lesions representing about 23% of all GI-NETs. 1 Type 1 GCs (GC-1) represent approximately 70%-80% of these NETs and are associated with chronic atrophic gastritis from primarily an autoimmune process or in rare instances Helicobacter pylori infection. 4 Type 2 lesions (approximately 5%-8% of GCs) occur with Zollinger-Ellison syndrome (ZES) primarily from gastrinomas with multiple endocrine neoplasia type 1 (MEN-1) mutations and to a lesser extent from sporadic gastrinomas. About 20% of patients with GC-2 due to ZES and MEN-1 develop aggressive lesions that metastasise. 5 Both GC-1 and GC-2 are associated with hypergastrinemia. 1 6 By contrast, GC-3 (14%-25% of upper tract NETs) are characterised by normal serum gastrin levels. 7 In
Significance of this study
What is already known on this subject?
▸ Type 1 and type 2 gastric carcinoids develop in response to hypergastrinemia. ▸ The genetic basis for type 1 gastric carcinoids is largely unknown. ▸ Some gastric carcinoid tumours contain MEN1 mutations. ▸ The functional significance of known mutations is ill-defined.
What are the new findings?
▸ A mouse model of gastric carcinoid was genetically engineered and demonstrated synergy between at least two gene loci-Men1 and somatostatin. ▸ Synergy between Men1 and somatostatin loci was required to achieve a threshold level of hypergastrinemia after augmentation by omeprazole, suggesting a possible genetic predisposition. ▸ Hypergastrinemia induced phosphorylation of the CDKN1B gene product p27 Kip1 , which promoted its translocation from the nucleus to the cytoplasm. ▸ Loss of p27 Kip1 was observed in human gastric carcinoids with atrophic gastritis.
How might it impact on clinical practice in the foreseeable future?
▸ Consider avoiding proton pump inhibitors in patients with atrophic gastritis. ▸ Provides additional molecular evidence to support the clinical use of CCKBR inhibitors in patients with type 1 and 2 gastric carcinoid prior to using somatostatin agonists, for example, octreotide. ▸ Consider trials of Skp2 and p27
Kip1 inhibitors for type 1 and 2 gastric carcinoid.
response to food, antral G cells secrete gastrin, which binds to the cholecystokinin-B receptor (CCKBR) located on enterochromaffin-like (ECL) cells to stimulate histamine release. 4 8-10 Subsequently, histamine stimulates acid secretion from parietal cells. 10 11 In addition to acid secretion, gastrin stimulates gastric epithelial cell proliferation, predominantly ECL cells that reside in the corpus. [12] [13] [14] [15] [16] Animal models of GI-NETs available to study the genetic landscape leading to tumour development are lacking. Although the outbred African rodent Mastomys natalensis and some rat species spontaneously develop carcinoid tumours, 17 18 their genetic background is ill-defined precluding definitive functional analysis of any mutations that contribute to tumour development. We previously reported that menin and somatostatin (Sst) inhibit gastrin expression. 19 20 Indeed, tissue-specific deletion of Men1 from the GI mucosa using Villin-Cre or Lgr5-Cre transgenes induces hypergastrinemia; however no gastrinomas were observed, 21 suggesting that additional mutations might be required. Since (Sst) stimulates menin gene expression in vitro, and both are inhibitors of gastrin, we hypothesised that combining the conditional deletion of Men1 with complete deletion of both Sst alleles might be sufficient to induce tumorigenesis. We report here that loss of both Men1 and Sst was sufficient to spontaneously generate GCs in about 2 years or in 6 months with proton pump inhibition of acid secretion. We used this genetically defined animal model of GI-NETs to analyse the molecular events sufficient for GC development, and compare them with the hallmarks of human GCs. CTAAAGCGCAT-GCTCCAGAC-3 0 (forward) and 5 0 -AGCTTT GCGT-TCCCGGGGTG-3 0 (reverse)). The mice were housed in a facility with a 12:12-h light-dark cycle with access to food and water ad libitum. Mouse genders used were equivalently distributed across the control and treatment groups (see online supplementary table S1). Experimental mice were fed omeprazole-laced chow (200 ppm, TestDiet, St. Louis, Missouri, USA) for 6 months. Animal experiments were conducted according to protocols approved by the University of Michigan's Committee on the Use and Care of Animals.
MATERIALS AND METHODS Human samples

Cell culture
Human gastric adenocarcinoma cell line (AGS) cells stably expressing the CCKBR (AGSE) (a gift from Dr Timothy Wang, Columbia University) 22 were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, California, USA) with 10% fetal bovine serum (FBS). STC-1 cells from a mouse intestinal tumour, 23 24 were cultured in DMEM high glucose (with glutamine, without pyruvate) in 10% FBS.
Cells were plated onto 6-well plates (1×10 6 ), serum-starved in DMEM and treated with gastrin (Leu 15 Gastrin I human, Sigma, St. Louis, Missouri, USA) for 24 h, with or without YM022 (Sigma). For peptone stimulated gastrin release experiments, STC-1 cells were treated with 2% peptone in glucosefree Hank's Balanced Salt Solution (HBSS) with 0.1% fatty acid free bovine serum albumin (BSA) for 2 h. The media was collected for gastrin analysis by ELISA. The cells were lysed for protein assays.
RT-qPCR
Total RNA was isolated from tissues using the RNeasy Mini kit (Qiagen) after DNase A digestion. cDNAs were synthesised using 500 ng of total RNA and the iScript cDNA synthesis kit (Bio-Rad, Hercules, California, USA). Quantitative PCR (qPCRs) was carried out using a thermal cycler (model C1000, Bio-Rad) with Platinum Taq DNA polymerase (Invitrogen) and SYBR Green dye (Molecular Probes, Carlsbad, California, USA). PCR reactions were performed in duplicate using the following conditions: 95°C for 1 min, 39 cycles of 95°C for 9 s and 65°C for 1 min followed by 55°C for 1 min. The primers used are listed in online supplementary table S2. Arbitrary units of the indicated mRNAs were normalised to Hprt mRNA and then expressed as fold increase over untreated C57BL/6 controls.
Western blot
Total cell proteins were obtained after homogenisation in radioimmunoprecipitation assay (RIPA) lysis buffer (Sigma-Aldrich) with the Complete Protease Inhibitor Cocktail (Roche, Indianapolis, Indiana, USA). Nuclear and cytoplasmic fractions were obtained using the NE-PER kit (Thermo Scientific) according to the manufacturer's instructions. Lysates were resolved on Novex 4%-20% Tris-Glycine gels (Life Technologies). Proteins were transferred to polyvinylidene difluoride membranes that were blocked in 5% BSA and incubated overnight at 4°C with primary antibodies (see online supplementary table S3). Protein signals were detected using the Odyssey Infrared System (Li-Cor Biosciences, Lincoln, Nebraska, USA) after incubation with infrared dye-labelled secondary antibodies.
Immunohistochemistry
Stomachs of mice were fixed in 10% formaldehyde solution; paraffin embedded and 5 μm sections were prepared. Sections 
CAG, chronic atrophic gastritis; IM, intestinal metaplasia.
were deparaffinised, protein blocked and stained with primary antibodies (see online supplementary table S3). For fluorescent detection, sections were incubated with Alexa Fluor-conjugated secondary antibodies for 1 h (1:200 dilution). ProLong Gold antifade reagent with 4 0 , 6-diamidino-2-phenylindole (DAPI, Invitrogen) was used for nuclear counterstaining. Avidin-biotin complex (Vectastain Elite ABC Kit) and diaminobenzidine (Vector Laboratories, Burlingame, California, USA) were used for detection using bright field microscopy. Images were taken using a Nikon inverted confocal microscope (Nikon, New York, USA) and Olympus BX53 microscope (Olympus, Tokyo, Japan).
AGSE and STC-1 cells were fixed for 20 min at room temperature in 4% paraformaldehyde, and then permeabilised for 5 min with 0.2% Triton X-100/phosphate buffered saline (PBS). After blocking with 1% donkey serum, cells were incubated with primary antibodies and stained as described above.
Plasma gastrin determination
Mice were fasted for 16 h before euthanisation. Blood was collected by cardiac puncture and the plasma was collected by centrifugation. Gastrin levels were measured by the Human/ Mouse/Rat Gastrin-I Enzyme Immunoassay Kit (RayBiotech, Georgia, USA), according to manufacturer's instructions.
Basal gastric acid content
Basal gastric acid content was determined as described previously, 21 and data were normalised to mouse body weight.
Statistical analyses
All reported values are the mean±SEM. Statistical analyses were performed using one-way analysis of variance (ANOVA) (GraphPad Prism 6, GraphPad Software, San Diego, California, USA). Tukey's method was applied for multiple comparisons after determination of significance by ANOVA. p<0.05 was considered significant.
RESULTS
Spontaneous development of GCs in Men1
We previously reported that tissue-specific deletion of Men1 from the GI mucosa using the Villin-Cre driver (Men1 ΔIEC ) induces hypergastrinemia and epithelial hyperplasia; however no tumours were observed, 21 suggesting that additional mutations might be required for malignant transformation of neuroendocrine cells. Sst stimulates menin gene expression in vitro, 20 and both are known inhibitors of gastrin gene expression and secretion. 19 20 25 Therefore we hypothesised that loss of both menin and Sst might be sufficient to induce tumorigenesis in neuroendocrine cells. To test this hypothesis, we bred the previously characterised Men1
ΔIEC mouse line to Sst −/− mice to produce Men1 ΔIEC ; Sst −/− chimaeras. We observed that after about 2 years, Men1
ΔIEC ; Sst −/− mice (n=9/10) spontaneously developed polyps in the corpi of the stomach (figure 1A). Stomachs from age-matched C57BL/6 (WT), Men1
ΔIEC , or Sst −/− mice did not develop polyps and there were no histological changes (figure 1B-D). Men1
ΔIEC ; Sst −/− mice showed corpus hyperplasia and tumours that infiltrated the submucosa and smooth muscle layers (figure 1E, F). H&E of the tumours revealed nests of mucosal and submucosal cells suggestive of endocrine tumours. The tumours were Hdc + ( figure 1G ) and ChgA + (see online supplementary figure S1A), confirming their neuroendocrine origin, and showed rare Ki67 + cells ( figure 1H ). By 24 months, Men1 ΔIEC ; Sst −/− mice were only modestly hypergastrinemic. G cell numbers and plasma gastrin levels were about 60% higher than wild-type (WT) mice (see online supplementary figure S2 ).
The number of HK-ATPase positive cells trended upwards in the Men1
ΔIEC ; Sst −/− mice, reflecting an increase in the total number of parietal cells (see online supplementary figure S3A-E). However, the number of parietal cells per gland was not significantly different (see online supplementary figure S3F), probably due to a concomitant increase in overall gland size. Nevertheless, HK-Atpase mRNA and basal gastric acidity were not different among the four genotypes at 2 years (see online supplementary figure S3G, H).
Acid suppression accelerated carcinoid development to 6 months
Given the prolonged timeline to observe ECL cell hyperplasia and tumours, we sought to identify conditions that might accelerate tumour formation. Like the Men1 ΔIEC ; Sst −/− mice, the African rodent Mastomys spontaneously develops GCs in about 2 years. 17 18 26 However with acid suppression, these rodents develop GCs in 4 months. 27 Therefore we examined whether suppressing acid secretion accelerated tumour development in the Men1 ΔIEC ; Sst −/− mice. Indeed after feeding omeprazolelaced chow for 6 months, Men1
ΔIEC ; Sst −/− mice (n=8/10) developed polyps in the corpus as observed in the 2-year-old mice ( figure 1I ). Histochemical analysis showed linear cords of ECL cells that infiltrated the mucosa along with nodular aggregates in the submucosa (figure 1J). These lesions were also Hdc-positive cells (figure 1K, L) and ChgA+ (see online supplementary figure 1B) . No changes in morphology were observed with omeprazole treatment in the WT, Men1
ΔIEC, or the Sst
mice (data not shown). Omeprazole feeding resulted in an approximately 60% decrease in basal gastric acid levels in all genotypes (see online supplementary figure S4A); however no significant loss of parietal cells was observed (see online supplementary figure S4B ) suggesting that the observed phenotype is more likely due to loss of parietal cell function as opposed to physical loss of these cells.
Carcinoid development required a threshold level of gastrin
To determine whether gastrin drives ECL tumour development, antral gastrin content and mRNA, and plasma gastrin levels were measured. Omeprazole treatment increased the number of gastrin-positive cells in all groups (figure 2A-H). To quantitate changes in expression, gastrin peptide was extracted from antral tissue and content was determined by ELISA. Omeprazole increased antral gastrin by approximately twofold in all genotypes (compared with respective untreated mice), except in the Men1 ΔIEC ; Sst −/− mice, where a marked fourfold increase in tissue gastrin was observed ( figure 2I ). In addition, gastrin mRNA levels increased by approximately 50% in all groups except in the Men1 ΔIEC ; Sst −/− mice where a twofold increase was observed compared with untreated mice (figure 2J). Coincident with the increase in antral gastrin content and mRNA, omeprazole treatment significantly increased plasma gastrin levels in all groups with the highest induction (threefold) occurring in the Men1 ΔIEC ; Sst −/− mice ( figure 2K ). This suggested that a certain threshold level of gastrin was required before ECL hyperplasia and tumour formation was observed.
Hypergastrinemia induced Cckbr expression in carcinoid tumours
To identify the signalling pathways activated in the ECL tumours, we excised polyps from the corpi of Men1 ΔIEC ; Sst −/− mice and performed a microarray analysis. As shown in the heat-map, there was a striking 16-fold increase in Cckbr expression observed in the polyps, compared with the adjacent visibly normal corpus areas from the same mouse ( figure 3A) . In addition, Hdc, somatostatin receptor 2 (Sstr2) and two transcriptionally regulated cyclin-dependent inhibitors were also induced (Cdkn2B and Cdkn1C) while other neuroendocrine markers, Tph1 and Gip, were reduced. Cckbr is expressed on ECL cells, and is activated by circulating gastrin that stimulates their Shown are the means±SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Scale bars: 100 μm. growth and proliferation. 12 13 28 The increase in tissue Cckbr mRNA observed on the microarray was validated by qPCR, western blot and immunohistochemistry (IHC) (figure 3B-F). As shown in figure 3B , omeprazole treatment resulted in no significant changes in Cckbr mRNA levels in any of the groups except the Men1 ΔIEC ; Sst −/− mice that exhibited a 75% increase in Cckbr mRNA in the absence of omeprazole and a nearly twofold increase with omeprazole. Although omeprazole treatment modestly increased gastrin expression in all genotypes, increased receptor expression was observed at a plasma gastrin >250 pg/mL, which was achieved only when both Men1 and Sst were deleted. Therefore, we concluded that a threshold level of hypergastrinemia was required to stimulate expression of its own receptor on ECL cells. Consistent with an increase in mRNA expression, there was a fourfold increase in Cckbr protein in the polyps from omeprazole-treated Men1 ΔIEC ; Sst −/− mice versus a 2.5-fold increase in the untreated Men1 ΔIEC ; Sst −/− mice compared with the other genotypes ( figure 3C, D) . In addition, examination of Cckbr expression by IHC showed significantly higher receptor density on the hyperplastic ECL cells (determined by HDC staining on serial sections) compared with adjacent visibly normal areas ( figure 3E ).
Increased Cckbr expression correlated with altered p27
Kip1 expression and cellular localisation A critical pathway in the pathology of endocrine tumours is loss of cyclin-dependent kinase inhibitor (CDKI) expression, specifically p27 Kip1 , which contributes to uncontrolled proliferation and subsequent malignant transformation. 29 30 The MEN4 syndrome is due to germline mutations in the CDKN1B locus. 31 32 To determine whether gastrin-driven carcinoids in our study correlated with p27
Kip1 levels, we studied p27 Kip1 protein expression in the polyps excised from omeprazole-treated Men1 ΔIEC ; Sst −/− mice. We observed a 30% decrease in total p27
Kip1 levels in the omeprazole-treated mice that developed carcinoids, compared with omeprazole-treated WT mice ( figure  4A, B) . The effects were most significant in the Men1 ΔIEC ; Sst −/− group, although a modest 15% decrease was observed in the Sst −/− mice that were unaffected after omeprazole treatment.
Since p27
Kip1 shuttles between the nucleus and cytoplasm, we isolated nuclear and cytosolic fractions from total cell lysates of polyps and examined protein expression in both fractions by western blot. No change in nuclear p27
Kip1 expression was observed with omeprazole treatment in WT, or in the Men1 ΔIEC mice (figure 4B). However, Sst deletion alone reduced nuclear p27 Kip1 expression by approximately 30%, an effect that was enhanced when combined with deletion of Men1 (approximately 60% reduction) and amplified by omeprazole ( approximately 92% reduction, figure 4A, B) . Since the reduction in total p27
Kip1 levels might be attributable to Skp2-mediated nuclear degradation following phosphorylation at Thr187, [33] [34] [35] [36] we first examined P-p27Thr187 expression in nuclear lysates. A 200% increase in P-p27
Thr187 expression was observed in the carcinoid tumours that correlated with higher Skp2 levels ( figure 4A, C) , suggesting increased degradation in the nucleus. Decrease in nuclear p27
Kip1 levels was associated with a corresponding increase in the cytosolic fractions ( figure 4A ). Sst deletion alone resulted in an approximately 30% increase in the cytosolic p27 Kip1 levels that was unaffected by omeprazole treatment. In contrast, combining Sst and Men1 deletion resulted in a twofold increase in cytosolic p27
Kip1 that was increased threefold with omeprazole treatment (figure 4B). No changes were observed in the WT or Men1 ΔIEC mice. The increase in p27
Kip1 in the cytoplasmic fraction was accompanied by accumulation of P-p27 Ser10 ( figure 4A, B) . Phosphorylation of p27
Kip1 at Ser10 facilitates its export from the nucleus to the cytoplasm where it either undergoes degradation, or is retained (blocking nuclear re-entry) after additional phosphorylation at Thr 198. 35 Increased expression of P-p27 Ser10 suggestive of accumulation prompted us to investigate P-p27
Thr198 in the cytoplasmic pool. Indeed, a threefold increase in P-p27Kip1
Thr198 expression was observed in carcinoid tumours ( figure 4D ). Since the polyps used to determine p27
Kip1 expression could possibly be a heterogeneous mixture of different cell types, we examined changes in phosphorylated forms of p27 Kip1 in ECL cells by immunofluorescence. We observed that Hdc + cells are rarely P-p27 Thr187 positive at baseline (no omeprazole); however a marked increase in expression was observed in the nuclei of omeprazole-treated Men1 ΔIEC ; Sst −/− mice (figure 4E) suggesting accelerated degradation. More interestingly, a dramatic increase in cytosolic P-p27
Thr198 expression (figure 4E) was observed in ECL cell tumours, indicating cytoplasmic retention of p27 Kip1 . Consistently, total p27 expression in untreated Men1 ΔIEC ; Sst −/− mice was predominantly nuclear in Hdc+ cells (see online supplementary figure S5A) while increased cytoplasmic expression was observed in the omeprazole-treated counterparts (see online supplementary figure S5B ). Taken together, our data demonstrates that carcinoid formation is associated with loss of nuclear p27 Kip1 , its export to and retention in the cytoplasm.
Gastrin exported p27
Kip1 from the nucleus in vitro
To directly test whether the observed effects on Cckbr and p27 Kip1 were mediated by gastrin, we treated human gastric AGSE cells with gastrin peptide for 24 h and examined changes in CCKBR and p27
Kip1 expression by IHC and western blotting. Kip1 , P-p27 Thr187 and Skp2 protein expressions in nuclear fraction (SP1 loading control); P-p27 Ser10 and P-p27
Thr198 in cytoplasmic fraction (glyceraldehyde-3-phosphate dehydrogenase (GAPDH) loading control). Nuclear and cytoplasmic fractions were prepared as described earlier and fraction purity was assessed using appropriate markers (nuclear fraction showed negligible GAPDH expression, and cytoplasmic fraction had negligible SP1 levels). (B) Quantitation of p27
Kip1 expression in nuclear and cytoplasmic fractions, expressed as integrated band intensities normalised to appropriate loading controls (n=4-5). Letters (a-e) denote significant differences in nuclear and cytoplasmic p27 Kip1 expressions compared with that of respective cellular fractions in untreated WT controls. Bars with different letters are significantly different from each other. Asterisk symbols denote significant differences in total cellular p27
Kip1 expressions compared with that in untreated WT controls. Bars with different asterisk symbols are significantly different from each other. Quantitation of P-p27
Thr187 expression in nuclear fraction (C), and P-p27
Thr198 expression in cytoplasmic fraction (D) expressed as ratio of total p27 Kip1 , after normalisation to SP1 and GAPDH loading controls, respectively (n=4-6). Shown are the means±SEM. *p<0.05, **p<0.01, ***p<0.001. (E) Immunofluorescent staining for P-p27 Thr187 , P-p27 Thr198 (arrows) and Hdc in the corpi of untreated or omeprazole-treated Men1 ΔIEC ; Sst −/− mice. Scale bars: 50 μm.
Immunostaining showed that gastrin treatment led to increased CCKBR expression (figure 5A). p27 Kip1 was predominantly nuclear in untreated cells; while treatment with gastrin led to a 70% decrease in the nuclear compartment and a threefold increase in the cytoplasmic fraction ( figure 5A-C) . Treatment with the CCKBR inhibitor YM022 or removal of gastrin from the media reversed the observed effects, demonstrating that nuclear export of p27 Kip1 and its retention in the cytoplasm are dependent on canonical gastrin signalling. To further confirm whether the effects observed were specific to gastrin, AGSE cells were treated with increasing concentrations of gastrin and nuclear and cytoplasmic levels of p27 Kip1 were examined. Interestingly, gastrin induced a dose-dependent decrease in p27
Kip1 that was associated with a concomitant increase in the cytoplasmic pool ( figure 5D ). To determine whether the observed gastrin-mediated effects occurred in enteroendocrine cells, we repeated the above experiments using the mouse enteroendocrine STC-1 cell line. Indeed, increased Cckbr expression and nuclear export of p27
Kip1 was observed with only 5 nM gastrin (see online supplementary figure S6A). Since STC-1 cells are known to release endogenous gastrin in response to stimuli, we further tested whether 2% peptone stimulated subsequently regulates p27 Kip1 . Peptone induced a time-dependent increase in gastrin secretion, which was unaffected by YM022 inhibitor (see online supplementary figure S6B ). This result confirmed that peptone-induced gastrin secretion is not mediated through the gastrin receptor. A robust increase in CCKBR expression, which was associated with loss of nuclear p27
Kip1 and its accumulation in the cytoplasm, was observed; whereas the YM022 inhibitor blocked these effects. It should be noted that only 5 nM gastrin was sufficient to observe effects in STC-1 cells, compared with AGSE cells that required at least 10 nM, perhaps due to the ability of STC-1 cells to generate endogenous gastrin. Taken together our data demonstrate that chronic gastrin stimulation induces expression of its own receptor that subsequently exports p27 Kip1 from the nucleus to the cytoplasm where it is retained. Loss of nuclear p27
Kip1 subsequently creates a permissive environment for uncontrolled proliferation (see online supplementary figure S6C ).
Increased Cckbr expression and loss of p27 Kip1 in human GCs
Archived surgical specimens from patients were obtained to examine CCKBR and p27
Kip1 expression in human GCs. A total of three patients with chronic atrophic gastritis and GCs were obtained (table 1) . Consistent with our animal model, all specimens contained nests of HDC + cells confirming ECL cell tumour origin. HDC + cell clusters exhibited robust CCKBR protein expression and significant reduction in total p27 Kip1 expression ( figure 6A, B) . Since it is likely that the human tumours developed over several years, possibly decades, we speculate that the initial signalling events leading to p27 Kip1 phosphorylation were a proximal event and that much of p27 Kip1 has been degraded, which contributed to tumour formation. 
Stomach
DISCUSSION
Although rare, GC tumours can arise in the setting of chronic atrophic gastritis and subsequent hypergastrinemia. 37 38 However, it is not understood what predisposes individuals to carcinoid development in the stomach. Prior outbred rodent models have shown that gain-of-function mutations in the Cckbr receptor create a genetic landscape that results in carcinoid development within 2 years. 39 40 We demonstrate in the current study that GCs arise once a threshold level of hypergastrinemia is achieved in mice carrying deletions of both Men1 and Sst loci. Sst regulates gastrin at the level of gene expression and peptide secretion. 25 In addition, Sst induces menin gene expression that inhibits gastrin gene expression. 20 Thus, we concluded that these two loci function synergistically to suppress gastrin. Moreover, it has been previously reported in cell culture models that gastrin stimulates the expression of its own receptor. 13 Therefore the effect of sustained hypergastrinemia amplifies Cckbr signalling in part through its ability to increase the density of Cckbr on responding cells. Based on the intensity of IHC staining relative to the remaining mucosa, ECL cells appear to exhibit a higher density of gastrin receptors and as a result would be more susceptible to the proliferative effects of the circulating hormone.
Having established in vivo that there was an increase in both gastrin and then Cckbr, we examined a mechanism by which hypergastrinemia stimulates ECL cell hyperplasia. It is known that many endocrine tumours are susceptible to reduced levels or function of p27 Kip1 , a cyclin-dependent inhibitor. 30 41-43 In fact, the MEN4 syndrome in human subjects is due to germline mutations in the CDKN1B ( p27 Kip1 ) locus. 31 Therefore we stained both mouse and human GCs for p27 Kip1 and found that there was a loss of nuclear p27
Kip1 with coincident accumulation in the cytoplasm where it has been reported to be oncogenic. 35 We speculate that loss of nuclear levels is in part attributable to cytoplasmic and nuclear degradation as evidenced by the appearance of P-p27
Thr187 and increased Skp2 expression. Skp2 levels are higher in cancers of the prostate, 44 lung, 45 46 pancreas 47 and colon. 45 48 Dose-dependent p27 Kip1 translocation in AGSE and STC-1 cell lines that express CCKBR revealed that changes in cellular p27 Kip1 levels and location occurred in response to its gastrin-mediated phosphorylation. Activation of the CCKBR initiates a cascade of signal transduction events that include an increase in intracellular calcium as well as the induction of protein kinase activity such as protein kinase C, Map kinases and Jak2/Stat3/PI3K/Akt. 49 50 Presumably, phosphorylation of p27
Kip1 in the nucleus due to nuclear kinase activity is ultimately what regulates the fate of this cyclin-dependent inhibitor. Thus, like the human tumours, hypergastrinemia in mice increased Cckbr expression, which modulated p27
Kip1 protein stability and localisation leading to ECL cell hyperplasia and eventually carcinoids (figure 7).
Men1 mutations have been reported in GCs and are perhaps one of several mechanisms predisposing human subjects to hypergastrinemia. 6 It is known that inactivating mutations in Men1 also creates a genetic landscape suitable for gastrinomas, but it is not understood what creates the preference for ECL versus G cell hyperplasia. Acid suppression was required to induce carcinoid formation in our model in addition to the deletion of Men1 and Sst, underscoring the impact an environmental trigger can exert on a permissive genetic environment. This combination of events might explain why patients on omeprazole rarely develop carcinoids-their lack of genetic predisposition.
Our data further confirms that deletion of Men1 alone does not favour carcinoid development, but rather cooperates with additional loci, for example, deletion of Sst. The study demonstrated that mutation of only two loci was sufficient to converge upon the cellular signals regulating gastrin gene expression and secretion, which subsequently elevated Cckbr expression and altered p27
Kip1 localisation, events critical for GC development. Since the mutation in Men1 was required to generate the phenotype, we conclude that our transgenic mouse model most closely mimics Type 2 GI-NETs, but awaits detailed analysis of relevant sites, for example, the duodenum and pancreas for evidence of gastrin-expressing cells. Upper GI-NETs are rare, and currently there are no mouse models available to better analyse NET pathogenesis or to test emerging therapies before proceeding to human trials. This is the first mouse model that faithfully recapitulates GC phenotype, thereby allowing preclinical testing approaches in the future. In summary, we define here in mechanistic terms how hypergastrinemia promotes the development of gastric NETs. Furthermore, the propensity to develop ECL hyperplasia reported here uncovers the potential for therapeutic targets, for example, specific Cckbr-dependent kinase pathways targeting p27
Kip1 , which can be tested to treat gastrin-dependent carcinoid tumours.
